Could the MIND diet help Alzheimer's patients fight depression and malnutrition?
NCT ID NCT07163923
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study examined the links between the MIND diet, depression, and malnutrition in 30 Alzheimer's patients compared to 30 healthy older adults. Researchers measured diet quality, nutritional status, and mental health using questionnaires and blood tests. The goal was to understand whether diet patterns are associated with better outcomes in Alzheimer's, but no treatment or intervention was given.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If the findings show a strong link, it could point toward dietary strategies to support Alzheimer's patients' mental and nutritional health.
- What could go wrong
- This is a small, completed observational study—it does not test a treatment, so it cannot prove cause and effect. Results may not apply to all Alzheimer's patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
60 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Oct 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This study was planned as a case-control study. The study was conducted on healthy individuals with AD who were admitted to Bolu Abant İzzet Baysal University Training and Research Hospital Neurology Outpatient Clinic and volunteered to participate in the study. In the study, according to the 5% significance level (α = 0.05), 80% statistical power (1-β = 0.80) and sample size calculation for two groups (AD and control group), it was determined that at least 30 individuals should be included in each group in order to detect a medium-large effect size (Cohen's d ≈ 0.66). Therefore, 30 AD and 30 healthy individuals (control group) who volunteered to participate in the study were included.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged over 60 years. * Diagnosed with Alzheimer's disease (AD) (for AD group) * Able to communicate with themselves or their companions * Healthy volunteers without systemic or neurological diseases (for control group) * Matching criteria: Age, gender, smoking status, and alcohol use Exclusion Criteria: * Chronic inflammatory diseases * Schizophrenia * Bipolar disorder * Amputations * Neoplastic disorders * End-stage liver disease * End-stage kidney disease
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alzheimer disease (AD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bolu Abant İzzet Baysal University, Faculty of Health Sciences
Bolu, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your phone might notice Alzheimer's decline before you do
- PET scans probe Brain's power plants in alcohol use disorder
- Gut bacteria may hold clues to memory decline
- Can a fake vagus nerve device fool the Body's inflammation response?
- Could a breath test reveal Parkinson's risk?
- Can a PET scan reveal the Brain's energy secrets in cocaine addiction?